Drug Approval | October 29, 2021
Boehringer Ingelheim announces EMA marketing authorisation for spesolimab
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Gini Health works in the domain of personalised healthcare
Acute therapies continue to report strong growth compared to chronic ones.
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Subscribe To Our Newsletter & Stay Updated
